COVID-19

Sessions

Wednesday, 23 November

10:50

COVID-19 implications for services and responses

10:50 to 12:20

Central square 3 (C3)

Oral presentation session

13:20

Drug use in diverse communities and settings

13:20 to 14:50

Networking zone 1 (N1)

e-poster guided tour

Gambling epidemiology and new trends

13:20 to 14:50

Insights zone 3 (I3)

Oral presentation session

15:00

Alcohol use and AUD during COVID-19 pandemic

15:00 to 16:30

Central square 1 (C1)

Oral presentation session

Short communications on alcohol: Covid, Ketamine, Cognition, Consumption

15:00 to 16:30

Networking zone 3 (N3)

Short communication session

Substance use and mental health disorders in Europe: prevalence, models of care, and implementation in a challenging COVID-19 context

15:00 to 16:30

Knowledge market 2 (K2)

Structured session

16:50

Economic recessions, COVID-19, socio-determinants of drug use and its harms: deaths of despair?

16:50 to 18:20

Central square 4 (C4)

Workshop

Improving knowledge, protecting health

16:50 to 18:20

Networking zone 3 (N3)

Short communication session

Thursday, 24 November

10:50

From Harm to Risk Reduction: OKANA’s 360o approach in Athens

10:50 to 12:20

Knowledge market 4 (K4)

Structured session

Problematic internet and videogame use

10:50 to 12:20

Insights zone 3 (I3)

Oral presentation session

13:20

Behavioral addictions: Diverse populations, challenges, and solutions

13:20 to 14:50

Networking zone 1 (N1)

e-poster guided tour

15:00

Drug deaths: A social, structural and systems analysis

15:00 to 16:30

Knowledge market 1 (K1)

Structured session

Substance use and mental health during COVID-19

15:00 to 16:30

Knowledge market 2 (K2)

Oral presentation session

The implementation and evaluation of “safer supply” programs in Canada as a response to an ongoing overdose crisis

15:00 to 16:30

Insights zone 4 (I4)

Structured session

16:50

Informing and delivering treatment

16:50 to 18:20

Networking zone 3 (N3)

Short communication session

Substance use, suicide and self-harm: epidemiology and prevention

16:50 to 18:20

Main stage

Structured session

Friday, 25 November

10:50

COVID-19-adapted addiction services and impact for service users

10:50 to 12:20

Insights zone 4 (I4)

Structured session

Interventions in Academia

10:50 to 12:20

Networking zone 1 (N1)

e-poster guided tour

13:20

Alcohol psychology and some epidemiology

13:20 to 14:50

Networking zone 4 (N4)

Short communication session

Behavioral addictions

13:20 to 14:50

Insights zone 3 (I3)

Short communication session

Changes and trends in how people are buying drugs

13:20 to 14:50

Insights zone 4 (I4)

Oral presentation session

Understanding drug use, risk and harm

13:20 to 14:50

Networking zone 2 (N2)

e-poster guided tour

Presentations

Wednesday, 23 November

10:50

Oral presentation

Substance Use and Substance Use Disorders in relation to COVID-19: Qualitative Experience of Users in Jordan

10:50 to 12:20

Central square 3 (C3)

Mayyada Wazaify

Oral presentation

Overdose deaths and the COVID-19 pandemic in British Columbia, Canada

10:50 to 12:20

Central square 3 (C3)

Alexis Crabtree

Oral presentation

Changes in social work practice and support for people who use drugs during the Covid-19 pandemic – a case study of Malmö, Sweden

10:50 to 12:20

Central square 3 (C3)

Torkel Richert

Oral presentation

Drug use and attitudes toward COVID-19 vaccination in a representative sample of undergraduate students

10:50 to 12:20

Central square 3 (C3)

Stelios Stylianou

Oral presentation

Using Opioids During the COVID-19 Pandemic: experiences of people who use opioids and their healthcare providers in Nova Scotia, Canada

10:50 to 12:20

Central square 3 (C3)

Emilie Comeau

13:20

e-poster

Cannabis use and aquisition in pandemic times – results from a sample of regular users in Germany

13:20 to 14:50

Networking zone 1 (N1)

Bernd Werse

e-poster

A retrospective overview of polydrug abuse in Tunisia

13:20 to 14:50

Networking zone 1 (N1)

Bilel Moslah

e-poster

Professionals’ views on challenges in inpatient substance abuse treatment during COVID-19 pandemic

13:20 to 14:50

Networking zone 1 (N1)

Eeva Ekqvist

e-poster

Tipping points surrounding motivation to change substance use patterns among seniors in the general population or with incarceration experience: are they all the same?

13:20 to 14:50

Networking zone 1 (N1)

Valérie Aubut

e-poster

Methodological challenges and policy relevance of studies on substance use in nightlife settings: the case of the Nightlife Study in the Netherlands

13:20 to 14:50

Networking zone 1 (N1)

Karin Monshouwer

e-poster

Incorporating Culture into The Treatment of Substance Use Disorder: A Narrative Review

13:20 to 14:50

Networking zone 1 (N1)

Odete Nombora

e-poster

COVID-19 related stressors and alcohol use among urban refugee youth in Kampala, Uganda

13:20 to 14:50

Networking zone 1 (N1)

Carmen Logie

e-poster

Harm reduction calls to action from young people who use drugs on the streets of Vancouver and Lisbon

13:20 to 14:50

Networking zone 1 (N1)

Joana Canedo

Oral presentation

Cryptocurrency trading as behavioral addiction: cross-sectional and longitudinal perspective from Finland

Online gambling and associated harms during the COVID-19 pandemic: A population study

Online gambling and F2P games in Canada: portrait and trends

Problem gambling among European adolescents: potential risk of gambling products and online gambling

15:00

Temporal changes in alcohol consumption associated with the COVID-19 interventions in Belgium: a wastewater-based approach

15:00 to 16:30

Central square 1 (C1)

Maarten Quireyns

Short communication

This Is Something That Changed My Life': A Qualitative Study of Patients' Experiences in a Clinical Trial of Ketamine Treatment for Alcohol Use Disorders

15:00 to 16:30

Networking zone 3 (N3)

Merve Mollaahmetoglu

Short communication

Changes in retrospectively recalled alcohol use and hazardous drinking pre, during, and post an alcohol sales prohibition in Botswana during COVID pandemic.

15:00 to 16:30

Networking zone 3 (N3)

J. Maphisa Maphisa

Short communication

Exploring the potential for Managed Alcohol Programmes during the COVID-19 pandemic in Scotland: Findings from a mixed methods study

15:00 to 16:30

Networking zone 3 (N3)

Hannah Carver

Short communication

Cognitive Functions in Early- Detoxified Alcohol-Dependent Inpatients and Their Association with Severity of Alcohol Dependence

15:00 to 16:30

Networking zone 3 (N3)

Prabhoo Dayal

Short communication

Efficacy of Cognitive Retraining Module for improving Cognitive Deficits of abstinent patients with Alcohol Dependence Syndrome and Opioid Dependence Syndrome in a Tertiary Care De-addiction Centre of Northern India

15:00 to 16:30

Networking zone 3 (N3)

Gauri Shanker Kaloiya

Short communication

Consumption of alcohol, tobacco and lifestyles in the population over 50 years old: Perception of quality and satisfaction with life

15:00 to 16:30

Networking zone 3 (N3)

Filipa Coelhoso

Short communication

Managed alcohol program in the low-threshold daily facility in the City of Brno, Czech Republic.

15:00 to 16:30

Networking zone 3 (N3)

Petr Blažek

Short communication

Thirty years of experience in Alcoholism treatment

15:00 to 16:30

Networking zone 3 (N3)

Inês Azevedo Silva

Oral presentation

Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries

15:00 to 16:30

Central square 1 (C1)

Gail Gilchrist

Oral presentation

Severe COVID-19 cases among patients admitted to treatment for alcohol and drug use disorders in Catalonia

15:00 to 16:30

Central square 1 (C1)

Jorge Palacio-Vieira

Oral presentation

Disentangling the 'COVID-19 alcohol paradox': reasons for changes in alcohol-specific disease burden during the COVID-19 pandemic in Germany

15:00 to 16:30

Central square 1 (C1)

Jakob Manthey

Oral presentation

1. What do we mean by psychiatric comorbidity or dual disorders?

15:00 to 16:30

Knowledge market 2 (K2)

Marta Torrens

Oral presentation

2. Impact of Covid19 on mental health and drug use: main findings from the EMCDDA trendspotter study

15:00 to 16:30

Knowledge market 2 (K2)

Franca Beccaria

Oral presentation

3. Psychiatric comorbidity in the European countries: prevalence and models of care

15:00 to 16:30

Knowledge market 2 (K2)

Francina Fonseca

Oral presentation

4. The dual diagnosis inpatient and outpatient treatment program in Ljubljana: practical implementatio

15:00 to 16:30

Knowledge market 2 (K2)

Nusa Segrec, Andrej Kastelic

Discussion

Discussion: Substance use and mental health disorders in Europe

15:00 to 16:30

Knowledge market 2 (K2)

Gabriele Fischer

16:50

Oral presentation

2. The impact of economic recessions on the harms of drug use and health responses, in Europe: a panel data analysis

16:50 to 18:20

Central square 4 (C4)

Bruno Casal

Oral presentation

3. Structural vulnerabilities and deaths of despair in Scotland, 1980-2021

16:50 to 18:20

Central square 4 (C4)

Mirjam Allik

Oral presentation

4. Economic conditions and opioids: An overview

16:50 to 18:20

Central square 4 (C4)

Sotiris Vandoros

Discussion

What lessons have we learn from past that apply to the COVID-19 induced recession? A structured debate

16:50 to 18:20

Central square 4 (C4)

Liesbeth Vandam

Oral presentation

1. The Impact of Economic Recessions on the Use of Illicit Drugs: a Systematic Review of Literature and a Meta-Analysis

16:50 to 18:20

Central square 4 (C4)

Claudia Costa Storti

Short communication

Successful microelimination of HCV among patients in the Romanian prison system

16:50 to 18:20

Networking zone 3 (N3)

Adrian Abagiu

Short communication

The synthetic cannabinoids ADB-FUBINACA and THJ-2201 decrease mitochondrial activity and ATP levels during neurodifferentiation of NG108-15 cells

16:50 to 18:20

Networking zone 3 (N3)

Rui Filipe Malheiro

Short communication

In vitro toxicity of the synthetic cannabinoids THJ-2201 and ADB-FUBINACA to human astrocytes

16:50 to 18:20

Networking zone 3 (N3)

Rafaela Silva

Short communication

Virtual Opioid User: Simulating the Effects of Counterfeit Pill Prevalence with a Control Theory Model

16:50 to 18:20

Networking zone 3 (N3)

Alexander Preiss

Short communication

The Influence of the Synthetic Cannabinoids AMB-FUBINACA, ADB-FUBINACA, AB-CHMINACA and THJ-2201 on In Vitro Viability and Senescence of SH-SY5Y Cells and Primary Rat Hippocampal Neurons

16:50 to 18:20

Networking zone 3 (N3)

Rita Roque Bravo

Short communication

Organ pathologies detected post-mortem in patients receiving opioid agonist treatment for opioid use disorder: a nationwide 2-year cross-sectional study

16:50 to 18:20

Networking zone 3 (N3)

Anne Berit Bech

Short communication

Impact of the COVID-19 pandemic on drug use in the Republic of North Macedonia

16:50 to 18:20

Networking zone 3 (N3)

Sanja Prosheva

Short communication

Non-pharmacological treatment interventions in UK drug and alcohol services: an exploratory study

16:50 to 18:20

Networking zone 3 (N3)

Karen Megranahan

Thursday, 24 November

10:50

Oral presentation

Experienced gratification and compensation in addictive behaviors: Investigating its relevance in different types of Internet-use disorders

Understanding first controlled gaming in teenagers. A qualitative study among young French daily or week-end gamers

Assessment of Criteria for Specific Internet-use Disorders (ACSID-11):Further development and validation of a new screening instrument capturing ICD-11 criteria for gaming disorder and other potential Internet-use disorders

Problematic gaming risk among European adolescents: A cross-national evaluation of individual and socio-economic factors

Effects of COVID-19 lockdowns on addiction to social networking sites and associations with changes in loneliness, sexual functioning, and eating styles

4. Harm Reduction and Covid 19: Hostel 'IONIS', an example of a holistic intervention for homeless drug users

10:50 to 12:20

Knowledge market 4 (K4)

Foteini Leobilla

Discussion

Challenges faced, political will, societal willingness and community approach of the harm reduction policy.

10:50 to 12:20

Knowledge market 4 (K4)

Athanasios Theocharis

Oral presentation

1. Steps forward in an attempt of OKANA to widen harm reduction to risk reduction: entries and facilities within a new concept based on the real needs

10:50 to 12:20

Knowledge market 4 (K4)

Athanasios Theocharis

Oral presentation

2. Streetwork and Outreach Networking

10:50 to 12:20

Knowledge market 4 (K4)

Lagakou Litsa

Oral presentation

3. Direct access to OST treatment and integrated therapy: Lessons learned from streets to community

10:50 to 12:20

Knowledge market 4 (K4)

Nikos Avgerinos

13:20

e-poster

Experiencing COVID-19 as gamblers: Availability restrictions, services, and habits

13:20 to 14:50

Networking zone 1 (N1)

Virve Marionneau

e-poster

Social media addiction and mental health among Algerian university students during the Covid-19 pandemic

13:20 to 14:50

Networking zone 1 (N1)

Nadia Sam

e-poster

Emerging adults 'in game': Research project on how Individual and family variables influence behaviors and motivations related to video games

13:20 to 14:50

Networking zone 1 (N1)

Susana Costa

e-poster

Screen Time and Mental Health in Algerian Population During the First Wave of the COVID-19 Pandemic

13:20 to 14:50

Networking zone 1 (N1)

Slimane Djillali

e-poster

Changing patterns in online addictive behaviours during COVID-19 pandemic

13:20 to 14:50

Networking zone 1 (N1)

João Castro Rodrigues

e-poster

Addictive behaviours among first year high education students – a descriptive study

13:20 to 14:50

Networking zone 1 (N1)

Gizela Cardoso

e-poster

Watching TV Series Motives (WTSMQ) y Binge-watching Engagement and Symptoms (BWESQ): Psychometric properties in Peruvian adults

13:20 to 14:50

Networking zone 1 (N1)

Fiorella Otiniano Campos

e-poster

The availability of offline gambling premises in Catalonia and its relationship with socioeconomic determinants

13:20 to 14:50

Networking zone 1 (N1)

Susanna Puigcorbé Alcalà

e-poster

Emotion regulation-enhanced group treatment for gambling disorder: a non- randomized pilot trial

13:20 to 14:50

Networking zone 1 (N1)

Viktor Månsson

e-poster

Gambling and social background in cases of suicide

13:20 to 14:50

Networking zone 1 (N1)

Kalle Lind

15:00

Oral presentation

1. Why people who use drugs need a safe regulated supply of all drugs

15:00 to 16:30

Insights zone 4 (I4)

Natasha Touesnard, Matthew Alexander Bonn

Oral presentation

3. A mixed methods evaluation of risk mitigation measures to address the dual public health crisis of COVID-19 and overdose

15:00 to 16:30

Insights zone 4 (I4)

Karen Urbanoski, Bernie Pauly

Oral presentation

4. A sea of need – Safe opioid supply service provider accounts of implementing admission priorities

5. Modeling safer supply programs: a qualitative evaluation of three safer opioid supply program models in British Columbia, Canada

15:00 to 16:30

Insights zone 4 (I4)

Andrew Ivsins, Geoff Bardwell

Oral presentation

2. Implementation of safe supply alternatives during intersecting COVID-19 and overdose health emergencies in British Columbia, Canada, 2021

The role of place-making dynamics in recovery from co-occurring disorders: An in-depth ethnographic study

15:00 to 16:30

Knowledge market 2 (K2)

Clara De Ruysscher

Oral presentation

Changes in mental health among drug users during Covid-19. Evidence from a repeated cross-sectional survey in Belgium

15:00 to 16:30

Knowledge market 2 (K2)

Elena Damian

Oral presentation

Online peer support for concurring mental health and addiction problems during the Covid19 pandemic: feeling of group inclusion and perceived effectiveness.

15:00 to 16:30

Knowledge market 2 (K2)

Raffaella Milani

Discussion

What can a social, structural and systems analysis tell us about drug-related deaths and what are the implications for policy and addiction science?

15:00 to 16:30

Knowledge market 1 (K1)

Anne Whittaker

Oral presentation

4. The role of Primary Care in the prevention of drug-related deaths: service provider perspectives

15:00 to 16:30

Knowledge market 1 (K1)

Betsy Thom

Oral presentation

5. Drug Policy and The Rise and Decline of Racial Stratification of Prescribing and Overdose Mortality

15:00 to 16:30

Knowledge market 1 (K1)

Brian Kelly

Oral presentation

1. Drug-related deaths among young people: a social, structural and systems autopsy

15:00 to 16:30

Knowledge market 1 (K1)

Aileen O'Gorman

Oral presentation

2. Drug-related deaths in prisons in England and Wales, 2015-2020: an examination of key trends and issues for policy and practice

15:00 to 16:30

Knowledge market 1 (K1)

Karen Duke

Oral presentation

3. The role of Primary Care in the prevention of drug-related deaths: Patient and family member perspectives

15:00 to 16:30

Knowledge market 1 (K1)

Katie Colliver

16:50

Oral presentation

Suicide and self-harm during COVID-19 and beyond.

Adolescent substance use, self-harm and suicide: Findings from the Northern Finland Birth Cohort 1986.

Restricting access to means: Public health approaches to reduce drug- and alcohol-related self-harm.

Outreach for socially marginalized trimorbid veterans in Denmark – preliminary results

16:50 to 18:20

Networking zone 3 (N3)

Henrik Thiesen

Short communication

A Feasibility Study of Mentalization Based Therapy for Antisocial personality disorder with substance use disorder in Norway- preliminary findings

16:50 to 18:20

Networking zone 3 (N3)

Katharina Morken

Short communication

Working in drug treatment and health care facilities

16:50 to 18:20

Networking zone 3 (N3)

Maitena Milhet

Short communication

Incidence and determinants of CoVID-19 in patients seeking treatment of Substance Use Disorder: a population-based linkage study

16:50 to 18:20

Networking zone 3 (N3)

Irene Lana

Short communication

Perspectives Pathways and Priorities of People with Lived and Living Experience of Substance Use: Informing Policies (P5 Project YXE)

16:50 to 18:20

Networking zone 3 (N3)

Barbara Fornssler

Short communication

The Treatment of Addictions in Portugal - What Future?

16:50 to 18:20

Networking zone 3 (N3)

João Feliz

Short communication

The effect of opioid agonist therapy on mental health of PWID in Ukraine

16:50 to 18:20

Networking zone 3 (N3)

Iryna Ivanchuk

Friday, 25 November

10:50

Oral presentation

4. Have predictors of drug addiction relapse changed during the COVID-19 pandemic? A prospective study of recovery pathways in the Netherlands, Belgium and UK

5. The impacts of COVID-19 pandemic on drug purchasing behaviours of people who use methamphetamine in Victoria, Melbourne.

2. A rapid assessment of take-home naloxone provision during COVID-19 in Europe

3. Will they accept the vaccine? A 2021 COVID-19 survey among 477 people who use drugs in Norway

10:50 to 12:20

Insights zone 4 (I4)

Gabrielle K. Welle-Strand

Oral presentation

1. Revised service delivery of opioid agonist treatment in Norway in 2021, the second year of the pandemic: a national cross-sectional study of treatment provider experiences

Addictology—A new collaboration to provide a peer-reviewed international journal in the field of drug demand reduction

10:50 to 12:20

Networking zone 1 (N1)

Beáta Gavurová

e-poster

Riscos & Desafios Program - only a click apart

10:50 to 12:20

Networking zone 1 (N1)

Carla Rocha

e-poster

Peer education and alcohol consumption: application of a training program for university students

10:50 to 12:20

Networking zone 1 (N1)

Katiane Holanda Fukamachi

e-poster

Fear of COVID-19 and its Impact on Maltese University Students’ Wellbeing and Substance Use

10:50 to 12:20

Networking zone 1 (N1)

Marilyn Clark

e-poster

Me and others': an evaluation of an interactive material for the prevention of non-substance addictions among high school students

10:50 to 12:20

Networking zone 1 (N1)

Santiago Almeida

e-poster

NIEBP: promoting an evidence-based approach to prevention

10:50 to 12:20

Networking zone 1 (N1)

Federico Pagnoni

e-poster

Creation of a database in Annaba’s addictional department

10:50 to 12:20

Networking zone 1 (N1)

Hanen Hocine

e-poster

A thousand on-line strategies and tools in academic addiction specialty education in post-COVID time: from necessity to quality

10:50 to 12:20

Networking zone 1 (N1)

Susana Henriques

e-poster

University students' perspectives on their preventive strategies to limit alcohol and cannabis use in festive contexts

10:50 to 12:20

Networking zone 1 (N1)

Mathieu Gougeon

e-poster

Facilitating an introduction to Evidence-based Prevention: INEP Plus

10:50 to 12:20

Networking zone 1 (N1)

Rachele Donini

13:20

Oral presentation

Monitoring online illicit drug market during the COVID-19 in Georgia

Who buys drugs using online sources in Ireland? Findings from the European Web Survey on Drugs

What can we learn from low-THC cannabis growers in Europe? A comparative transnational study of 1635 small-scale cannabis growers in Italy and Switzerland

Brokered Illegal Drug Sales as a Measure of Local Demand

Novel interventions to help citizens with hazardous substance use and prevent driving under the influence of alcohol or drugs (DUI)

13:20 to 14:50

Networking zone 4 (N4)

Kristine Rømer Thomsen

Short communication

Young, drunk, and fast: the paradoxical effects of hazardous drinking on cognitive performance in younger adults

13:20 to 14:50

Networking zone 4 (N4)

Anna Powell

Short communication

A Literature Review, using a Systematic Approach, on Effective Interventions and Approaches in the Delivery of Integrated Alcohol Services in Community Settings

13:20 to 14:50

Networking zone 4 (N4)

Elizabeth McCarthy

Short communication

Influence of alcohol use and other addictive disorders in the costs of emergency department frequent use

13:20 to 14:50

Networking zone 4 (N4)

Clara Oliveras Salvà

Short communication

Social alcohol cue reactivity in the brain: role of craving and social processes in adolescent and adult alcohol users

13:20 to 14:50

Networking zone 4 (N4)

Lauren Kuhns

Short communication

Alcohol Poisoning Outbreak in Iranian Adult Population During the COVID-19 Pandemic: A Prospective Cross-sectional Linkage Study from 13 Toxicology Referral Centers in Iran

13:20 to 14:50

Networking zone 4 (N4)

Hossein Hassanian-Moghaddam

Short communication

Initial efficacy of a new goal-oriented intervention for impulsive and sensation-seeking adolescents involving a digital game and MI-based interview

13:20 to 14:50

Networking zone 4 (N4)

Nuri Wieland

Short communication

Assessing specific strategies for regulating addiction related impulses and cravings

Escapism and excessive online behaviors during the COVID-19 pandemic: A longitudinal study in Finland

Reward processing in excessive and problematic use of social media: a neurophysiological study.

Personality traits predict addictive behaviour: A prospective study

Problematic smartphone use, but not daily duration of use, is associated with anxiety and depression in adolescents

Risky decision making in individuals with tendencies towards specific Internet-use disorders: Results from the Cards & Lottery Task

The use of mobile F2P games in everyday life : The experiences of gamers during the COVID-19 pandemic.

13:20 to 14:50

Insights zone 3 (I3)

Jean-philippe Laforge

e-poster

A systematic review of self-report and behavioural measures of the Addiction Neuroclinical Assessment constructs of incentive salience and negative emotionality, in adults who use psychoactive drugs.

13:20 to 14:50

Networking zone 2 (N2)

Maria Bravo Aguilera

e-poster

Abuse of prescription psychoactive medicines

13:20 to 14:50

Networking zone 2 (N2)

Darja Lavtar

e-poster

Changes in substance use during the COVID-19 pandemic: Longitudinal analysis of risk behavior and mental health of MSM using HIV pre-exposure prophylaxis

13:20 to 14:50

Networking zone 2 (N2)

Babette Lea Winter

e-poster

Non-prescribed buprenorphine and reduction in illicit opioids use among individuals with opioid use disorder: a longitudinal study

13:20 to 14:50

Networking zone 2 (N2)

Raminta Daniulaityte

e-poster

Sexualized substance use, consumption motives and risk factors for relapse of addiction patients. Results of a cross-sectional study in addiction treatment facilities in Germany.

13:20 to 14:50

Networking zone 2 (N2)

Daniel Deimel

e-poster

How hair keeps track: Associations between hair concentrations of psychoactive substances and steroid hormones in a large cohort sample of young adults in Switzerland

13:20 to 14:50

Networking zone 2 (N2)

Lydia Johnson-Ferguson

e-poster

Changes in sexualised and non-sexualised drug use among LGBT+ people during the COVID-19 pandemic: A systematic review

13:20 to 14:50

Networking zone 2 (N2)

Dean Connolly

e-poster

Four-year long wastewater-based monitoring of illicit drug consumption pilot project in Switzerland

13:20 to 14:50

Networking zone 2 (N2)

Livia Andrani

e-poster

How are profiles of substance use linked to social function in the following seven years?

13:20 to 14:50

Networking zone 2 (N2)

Sidsel Karsberg

e-poster

Suicide and self-harm among people prescribed opioid agonist treatment in New South Wales: a retrospective data linkage study

13:20 to 14:50

Networking zone 2 (N2)

Samantha Colledge-Frisby